What is the guideline-recommended first-line antibiotic for cellulitis caused by Pseudomonas aeruginosa in an adult with normal renal function and no β‑lactam allergy?

Guideline-Based Antibiotic for Pseudomonas Cellulitis

For cellulitis caused by Pseudomonas aeruginosa in an adult with normal renal function and no β-lactam allergy, use an antipseudomonal β-lactam such as ceftazidime 2g IV every 8 hours, cefepime 2g IV every 8-12 hours, or piperacillin-tazobactam 3.375-4.5g IV every 6 hours as monotherapy if susceptibility testing confirms susceptibility to these agents 1, 2.

Treatment Algorithm Based on Resistance Pattern

For Susceptible Pseudomonas (Non-DTR)

When susceptibility testing shows the organism is susceptible to traditional antipseudomonal agents:

• First-line options (choose one based on susceptibility):

  • Ceftazidime 2g IV every 8 hours 3
  • Cefepime 2g IV every 8-12 hours 3, 4
  • Piperacillin-tazobactam 3.375g IV every 6 hours (or 4.5g every 6 hours for severe infections) 3, 1
  • Ciprofloxacin 400mg IV every 12 hours 1

• Monotherapy is preferred over combination therapy for patients who are not in septic shock and when susceptibility is confirmed 5, 2

For Difficult-to-Treat Resistant (DTR) Pseudomonas

If the organism shows resistance to ceftazidime, cefepime, piperacillin-tazobactam, carbapenems, and fluoroquinolones:

• First-line novel agents (if susceptible):

  • Ceftolozane-tazobactam 1.5g IV every 8 hours 2, 1, 2, 6
  • Ceftazidime-avibactam 2.5g IV every 8 hours 2, 1, 2, 6

• Alternative agents:

  • Imipenem-cilastatin-relebactam 1.25g IV every 6 hours 2, 1
  • Cefiderocol (particularly if metallo-β-lactamases present) 2, 6
  • Colistin-based therapy (5mg CBA/kg IV loading dose, then 2.5mg CBA × [1.5 × CrCl + 30] IV every 12 hours) 1

Key Clinical Considerations

Combination therapy is NOT routinely recommended for Pseudomonas cellulitis unless the patient is in septic shock or at high risk of death 5, 2. The evidence shows that monotherapy with an active agent is as effective as combination therapy for non-critically ill patients 5.

Important caveats:

• If the patient has received a β-lactam within the previous 3 months, consider using a fluoroquinolone (ciprofloxacin or levofloxacin 750mg) to avoid selecting resistant organisms 7
• For patients with risk factors for Pseudomonas (prolonged hospitalization, prior antibiotic use, respiratory devices), empiric dual coverage may be warranted initially until susceptibilities return 7, 4
• Aminoglycoside monotherapy should never be used for Pseudomonas infections outside of urinary tract infections 5, 1

Duration and Monitoring

Treatment duration should be 7-14 days depending on clinical response and severity 8, 1. Switch to oral therapy (ciprofloxacin 500-750mg twice daily or levofloxacin 750mg daily) when clinically stable, typically after 3-5 days of IV therapy 7, 9.

The critical pitfall to avoid: Do not use traditional cellulitis antibiotics (cephalexin, dicloxacillin, clindamycin) for confirmed Pseudomonas cellulitis, as these lack antipseudomonal activity 10. Standard cellulitis regimens target streptococci and Staphylococcus aureus, not Pseudomonas 8, 10.